Arcturus therapeutics to present at the barclays 26th annual global healthcare conference

San diego--(business wire)---- $arct #clinicaltrial--arcturus therapeutics holdings inc. (the “company”, “arcturus”, nasdaq: arct), a global late-stage clinical messenger rna medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the company will present at a fireside chat hosted by barclays 26th annual global healthcare conference in miami, on thursday, march 14, 2024, at 11:45 a.m. eastern time. a webcast and repla.
ARCT Ratings Summary
ARCT Quant Ranking